Page last updated: 2024-10-30

mesalamine and Substance Withdrawal Syndrome

mesalamine has been researched along with Substance Withdrawal Syndrome in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
" Treatment-related adverse events were rare."2.68Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. ( Arora, S; Hanauer, S; Miner, P; Robinson, M; Schwartz, J, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miner, P1
Hanauer, S1
Robinson, M1
Schwartz, J1
Arora, S1

Trials

1 trial available for mesalamine and Substance Withdrawal Syndrome

ArticleYear
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:2

    Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Colitis, Ulcerative;

1995
chemdatabank.com